Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT02117336 · SUSPENDED
Trial details
- NCT number
- NCT02117336
- Sponsor
- Piramal Enterprises Limited
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-10-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.